Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP881039.RAMOQLSsBAH_bwrpwR5_VRr-L6ohnNFcBqEwRnMd4VC7I130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP881039.RAMOQLSsBAH_bwrpwR5_VRr-L6ohnNFcBqEwRnMd4VC7I130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP881039.RAMOQLSsBAH_bwrpwR5_VRr-L6ohnNFcBqEwRnMd4VC7I130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP881039.RAMOQLSsBAH_bwrpwR5_VRr-L6ohnNFcBqEwRnMd4VC7I130_provenance.
- NP881039.RAMOQLSsBAH_bwrpwR5_VRr-L6ohnNFcBqEwRnMd4VC7I130_assertion description "[Treatment of CD40 or BCR activated CLL cells with PCI-32765 results in inhibition of BTK tyrosine phosphorylation and also effectively abrogates downstream survival pathways activated by this kinase including ERK1/2, PI3K, and NF-?B.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP881039.RAMOQLSsBAH_bwrpwR5_VRr-L6ohnNFcBqEwRnMd4VC7I130_provenance.
- NP881039.RAMOQLSsBAH_bwrpwR5_VRr-L6ohnNFcBqEwRnMd4VC7I130_assertion evidence source_evidence_literature NP881039.RAMOQLSsBAH_bwrpwR5_VRr-L6ohnNFcBqEwRnMd4VC7I130_provenance.
- NP881039.RAMOQLSsBAH_bwrpwR5_VRr-L6ohnNFcBqEwRnMd4VC7I130_assertion SIO_000772 21422473 NP881039.RAMOQLSsBAH_bwrpwR5_VRr-L6ohnNFcBqEwRnMd4VC7I130_provenance.
- NP881039.RAMOQLSsBAH_bwrpwR5_VRr-L6ohnNFcBqEwRnMd4VC7I130_assertion wasDerivedFrom befree-2016 NP881039.RAMOQLSsBAH_bwrpwR5_VRr-L6ohnNFcBqEwRnMd4VC7I130_provenance.
- NP881039.RAMOQLSsBAH_bwrpwR5_VRr-L6ohnNFcBqEwRnMd4VC7I130_assertion wasGeneratedBy ECO_0000203 NP881039.RAMOQLSsBAH_bwrpwR5_VRr-L6ohnNFcBqEwRnMd4VC7I130_provenance.
- befree-2016 importedOn "2016-02-19" NP881039.RAMOQLSsBAH_bwrpwR5_VRr-L6ohnNFcBqEwRnMd4VC7I130_provenance.